|
Volumn 357, Issue 9260, 2001, Pages 957-958
|
HIV-1 infection and risk of tuberculosis after rifampicin treatment [4] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ISONIAZID;
RIFAMPICIN;
ANTIBIOTIC PROPHYLAXIS;
CLINICAL FEATURE;
COTE D'IVOIRE;
DISEASE COURSE;
ENDEMIC DISEASE;
HAITI;
HIGH RISK POPULATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INCIDENCE;
INFECTION RISK;
LETTER;
LONG TERM CARE;
MINER;
PREVALENCE;
PRIORITY JOURNAL;
RECURRENT INFECTION;
RISK FACTOR;
SILICOSIS;
SOUTH AFRICA;
TREATMENT INDICATION;
TREATMENT OUTCOME;
TUBERCULOSIS;
|
EID: 0035942016
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)71656-1 Document Type: Letter |
Times cited : (5)
|
References (5)
|